SABBY MANAGEMENT LLC 13D/13G Filings for Cocrystal Pharma, Inc. (COCP)

SABBY MANAGEMENT LLC 13D and 13G filings for Cocrystal Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-02
09:53 am
Sale		 2023-12-31 13G Cocrystal Pharma, Inc.
COCP		 SABBY MANAGEMENT LLC 0
0.000%		 -420,710decrease
(Position Closed)		 Filing
2023-01-10
11:40 am
Sale		 2022-12-31 13G Cocrystal Pharma, Inc.
COCP		 SABBY MANAGEMENT LLC 420,710
11.000%		 -57,467decrease
(-12.02%)		 Filing
2022-01-03
9:47 pm
Sale		 2021-12-31 13G Cocrystal Pharma, Inc.
COCP		 SABBY MANAGEMENT LLC 478,177
11.000%		 -333,490decrease
(-41.09%)		 Filing
2021-05-12
2:13 pm
Purchase		 2021-05-05 13G Cocrystal Pharma, Inc.
COCP		 SABBY MANAGEMENT LLC 811,667
11.000%		 811,667increase
(New Position)		 Filing
2021-01-05
09:26 am
Sale		 2020-12-31 13G Cocrystal Pharma, Inc.
COCP		 SABBY MANAGEMENT LLC 0
0.000%		 -288,462decrease
(Position Closed)		 Filing